Human gene
VWF von Willebrand factor
4 disease groups in OMIA reach this gene, through the animal gene that Ensembl gives as its ortholog. The page shows the chain. It does not say whether an animal is a model of a human disease.
Animal diseases
By each group's best natural-model score, highest first. How the score works.
| OMIA group | Name | Species | Animal gene | Ortholog | The chain reached | Best score |
|---|---|---|---|---|---|---|
| 1056 | Von Willebrand disease, generic | pig | VWF | one to one | Drug |
65.4
|
| 1058 | Von Willebrand disease III | dog | VWF | one to one | Drug |
65.4
|
| 1058 | Von Willebrand disease III | pig | VWF | one to one | Drug |
65.4
|
| 1339 | Von Willebrand disease II | dog | VWF | one to one | Drug |
63.4
|
| 1057 | Von Willebrand disease I | dog | VWF | one to one | Drug |
62.1
|
Target evidence
Each Open Targets association between this gene and a human disease that a disease group reached.
| Human disease | Mondo | Score | Evidence |
|---|---|---|---|
| von Willebrand disease 2 | MONDO:0013304 | 0.82 | 354 |
| von Willebrand disease 3 | MONDO:0010191 | 0.80 | 385 |
| von Willebrand disease 1 | MONDO:0008668 | 0.79 | 416 |
| platelet-type von Willebrand disease | MONDO:0008332 | 0.61 | 2,055 |
| Bernard-Soulier syndrome | MONDO:0009276 | 0.07 | 79 |
Drugs
Each ChEMBL drug that acts on this gene.
| Drug | How | Latest stage |
|---|---|---|
| Caplacizumab | inhibitor | Approved |
| Vonicog Alfa | exogenous protein | Approved |
| Von Willebrand Factor Human | exogenous protein | Approved |
| Egaptivon Pegol | inhibitor | Phase 2 |
The drug data is ChEMBL's, under CC BY-SA 3.0, and came through Open Targets release 26.09.